Avi Wallerstein (surgeon)

Wallerstein is one of 14 surgeons in North America with the designation to teach LASIK by the developers of the first LASIK microkeratome (Chiron), and one of the first surgeons in North America to use Bausch & Lomb’s Technolas 217 laser and Hansatome Keratome. Wallerstein is one of two National Medical Directors for LASIK MD (2001-present). Wallerstein was awarded the American Society of Cataract and Refractive Surgery Best Scientific Paper prize in 2003. .

Wallerstein is also Director of Refractive Surgery at the Royal Victoria Hospital, where he performs surgeries. As of 2007, LASIK MD performs approximately 40% of the laser vision correction procedures in Canada. Wallerstein completed his medical degree at Queen’s University in Canada and then specialized in ophthalmology (FRCSC) at McGill University in Montreal.

In 2001, he and Mark Cohen founded LASIK MD, Canada s largest provider of laser refractive surgery. Avi Wallerstein is a Canadian laser eye surgeon who practices in Montreal and Toronto.

He completed his post-doctoral fellowship training in cornea and laser refractive surgery at North Shore University Hospital and New York University in New York Wallerstein is Director of Refractive Surgery and Assistant Professor of Ophthalmology at McGill University, where he teaches ophthalmologists-in-training.